Alex Gorsky Reports 381 Promised Fee Shares Deferral on IBM Form 4
Rhea-AI Filing Summary
Alex Gorsky, an IBM director, reported a non‑derivative acquisition on 09/30/2025 involving 381 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan. Those shares were recorded at a per‑share value of $282.16. Following the transaction, Gorsky beneficially owns 32,805 shares of IBM common stock on a direct basis. The filing notes the shares are part of a deferred compensation arrangement and that distribution of the Promised Fee Shares is deferred until retirement. This Form 4 reflects a routine fee deferral by a director rather than an open‑market purchase or sale.
Positive
- Director fee deferral into equity aligns management incentives with shareholders by increasing director stock ownership
- Full disclosure provided including transaction date, share amount (381), per‑share value ($282.16), and post‑transaction holdings (32,805)
Negative
- None.
Insights
TL;DR: Director deferred board fees into equity; routine governance practice signaling alignment with long‑term shareholder interests.
The filing documents a standard deferral of board compensation into Promised Fee Shares under IBM's director deferred compensation plan. Deferrals that convert fees into common stock are common governance tools to align directors with shareholder outcomes. The material details—381 shares at $282.16 and a total direct holding of 32,805 shares—are clearly disclosed and the distribution timing is tied to retirement, which limits near‑term market impact. This is a non‑market, plan‑driven transaction.
TL;DR: Administrative Form 4 reporting a plan conversion; compliance appears complete with necessary disclosures.
The Form 4 provides required Section 16 disclosure for a director converting deferred fees into Promised Fee Shares. It includes transaction date, share amount, value per share, and post‑transaction beneficial ownership. The filing indicates distribution is deferred until retirement, which is appropriate to disclose for corporate reporting and insider trading compliance. No exercise or open‑market trade is reported.